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All metal salts and solvents were obtained from Sigman-Aldrich and used without further 
purification. 1H and 13C NMR spectra were recorded on a Varian 500 Mhz, Varian 400 
Mhz or a Varian 300 Mhz spectrometer. High-resolution mass spectra were provided by 
the California Institute of Technology Mass Spectrometry Facility using JEOL JMS-
600H High Resolution Mass Spectrometer. 
 
 
General Procedures 
 
Procedure A for preparative scale (0.5 mmol) oxidation of alkenes (isolation): 
PdCl2(PhCN)2 (0.05 mmol, 19.2 mg), CuCl2•2H2O (0.05 mmol, 8.5 mg) and NaNO2 
(0.025 mmol, 1.7 mg) were weighed into a 20 mL vial charged with a stir bar. The vial 
was sparged for 1 minute with oxygen (1 atm, balloon). Premixed and oxygen saturated t-
BuOH (7.5 mL) and MeNO2 (0.5 mL) was added followed by the alkene (0.5 mmol). The 
solution was saturated with oxygen by an additional 30 seconds of sparging. The reaction 
was then allowed to stir at room temperature (20-25ºC) for 4 h under 1 atm oxygen 
(balloon). Next, the reaction was quenched by addition to water (ca. 50mL) and extracted 
three times with dichloromethane (ca. 25 mL). The combined organic layers were 
subsequently washed with a saturated solution of NaHCO3 and dried over Na2SO4. The 
solvent was removed under reduced pressure and the desired aldehyde product was 
purified using flash chromatography (pentane/ether). The selectivity was calculated by 1H 
NMR analysis of the unpurified reaction mixture. Long relaxation delays (d1=10) were 
applied due to the long T1 of the aldehydic proton signal. 
 
Procedure B for analytical scale (0.2 mmol) oxidation of alkenes (NMR analysis): 
PdCl2(PhCN)2 (0.02 mmol, 7.7 mg), CuCl2•2H2O (0.02 mmol, 3.6 mg) and NaNO2 (0.01 
mmol, 0.7 mg) were weighed into a 8 mL vial charged with a stir bar. The vial was 
sparged for 1 minute with oxygen (1 atm, balloon). Premixed and oxygen saturated t-
BuOH (3 mL) and MeNO2 (0.2 mL) was added followed by the alkene (0.2 mmol). The 
solution was saturated with oxygen by an additional 15 seconds of sparging and then 
sealed under an atmosphere of oxygen. The reaction was then allowed to stir at room 
temperature (20-25ºC) for 4 h. Next, the reaction was quenched by addition to water (ca. 
10mL) and extracted three times with dichloromethane (ca. 5 mL). The combined organic 
layers were subsequently washed with a saturated solution of NaHCO3 and dried over 
Na2SO4. After volatiles were removed under reduced pressure, nitrobenzene was added 
as an internal standard. The resulting solution was subsequently subjected to 1H NMR 
analysis to determine yield and selectivity. 
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Procedure for Tsuji–Wacker oxidations: 
PdCl2 (1.8 mg, 0.01 mmol) and CuCl (9.9 mg, 0.1 mmol) were weighed into a 8 mL vial. 
DMF (0.7 mL) and water (0.1 mL) were both added to the vial. The vial was sparged 
with oxygen (1 atm, balloon) for 3 minutes. The solution was stirred for another 1 h 
before alkene (0.1 mmol) was added. The reaction was stirred for at room temperature 
(20-25ºC).  After 24 h, the reaction mixture was quenched by addition of water (ca. 10 
mL) and extracted 3 times with dichloromethane (ca. 5 mL). The combined organic 
layers were subsequently washed with a saturated solution of LiCl(aq). After volatiles 
were removed under reduced pressure, nitrobenzene was added as an internal standard. 
The resulting solution was subsequently subjected to 1H NMR analysis to determine yield 
and selectivity.   
 
 
Characterization 
 
 
tert-Butyldimethyl(oct-1-en-4-yloxy)silane: Prepared according to the literature.1 1H 
NMR (500 MHz, CDCl3) δ 5.87 – 5.74 (m, 1H), 5.07 – 5.02 (m, 1H), 5.02 – 4.99 (m, 1H), 
3.68 (p, J = 5.8 Hz, 1H), 2.29 – 2.14 (m, 2H), 1.50 – 1.21 (m, 6H). 0.89 (s, 9H), 0.88 (m, 
3H), 0.05 (s, 6H). Spectral data were in accordance with the literature.1 
 
 
Oct-1-en-4-yl acetate: 4-Dimethylaminopyridine (122mg, 1 mmol) was weighed into a 
flask with a stir bar. Dichloromethane (10 mL), 1-octen-4-ol (1.54 mL, 10 mmol), acetic 
anhydride (1.9 mL, 20 mmol) was added to the vial and stirred overnight (10 hours). The 
reaction mixture was diluted with water (ca. 125 mL) and extracted with 
dichloromethane (ca. 50 mL x3) and the combined organics were washed with brine and 
subsequently dried over MgSO4. Purification by column chromatography gave the 
desired compound (1.52g, 89% yield) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 
5.73 (ddt, J = 17.2, 10.2, 7.1 Hz, 1H), 5.08 – 5.00 (m, 2H), 4.89 (ddd, J = 12.7, 6.6, 5.7 
Hz, 1H), 2.34 – 2.22 (m, 2H), 2.01 (s, 3H), 1.59 – 1.47 (m, 2H), 1.45 – 1.17 (m, 4H), 0.96 
– 0.81 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 170.71, 133.78, 117.47, 73.27, 38.62, 
33.24, 27.43, 22.49, 21.17, 13.93. HRMS (EI+ ) calc'd for C7H13O2 (M-CH2CHCH2) 
129.0916, found 129.0917. 
 
 
4-Methoxyoct-1-ene: NaH (60wt% dispersion in mineral oil, 600 mg, 15 mmol) was 
weighed into a flask with a stir bar. Tetrahydrofuran (10 mL) was added to the vial and 
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the mixture was cooled to 0 ºC. 1-Octen-4-ol (1.54 mL, 10 mmol) were added slowly to 
the suspension. MeI (0.75 mL, 12 mmol) was next added slowly to the reaction mixture. 
The reaction mixture was allowed to warm to room temperature and stirred overnight (ca. 
10 h). The reaction mixture was diluted with water (ca. 125 mL) and extracted with 
diethyl ether (ca. 50 mL x3) and the combined organics were washed with brine and 
subsequently dried over MgSO4. Purification by column chromatography gave the 
desired compound (1.01g, 71% yield) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 
5.82 (ddt, J = 17.2, 10.2, 7.1 Hz, 1H), 5.06 (m, 2H), 3.34 (s, 3H), 3.20 (p, J = 5.9 Hz, 1H), 
2.26 (m, 2H), 1.47 (m, 2H), 1.31 (m, 4H), 0.90 (m, 3H). Spectral data were in accordance 
with the literature.2 
 
 
(but-3-en-1-yloxy)benzene: Prepared according to the literature.3 1H NMR (500 MHz, 
CDCl3) δ 7.31 – 7.26 (m, 2H), 6.97 – 6.92 (m, 1H), 6.92 – 6.90 (m, 2H), 5.95 (ddt, J = 
17.1, 10.3, 6.7 Hz, 1H), 5.20 – 5.09 (m, 2H), 4.03 (t, J = 6.7 Hz, 2H), 2.60 – 2.51 (m, 
2H). Spectral data were in accordance with the literature.3 
 
 
((oct-1-en-4-yloxy)methyl)benzene: NaH (60wt% dispersion in mineral oil, 600 mg, 15 
mmol) was weighed into a flask with a stir bar. Tetrahydrofuran (10 mL) was added to 
the vial and the mixture was cooled to 0 ºC. 1-Octen-4-ol (1.54 mL, 10 mmol) was added 
slowly to the suspension. Benzyl bromide (1.4 mL, 12 mmol) was next added slowly to 
the reaction mixture. The reaction mixture was allowed to warm to room temperature and 
stirred overnight (ca. 10 h). The reaction mixture was diluted with water (ca. 125 mL) 
and extracted with diethyl ether (ca. 50 mL x3) and the combined organics were washed 
with brine and subsequently dried over MgSO4. Purification by column chromatography 
gave the desired compound (1.48g, 68% yield) as a colorless oil. 1H NMR (500 MHz, 
CDCl3) δ 7.41 – 7.34 (m, 4H), 7.33 – 7.27 (m, 1H), 5.89 (ddt, J = 17.2, 10.2, 7.1 Hz, 1H), 
5.21 – 5.06 (m, 2H), 4.60 (d, J = 15.0 Hz, 1H), 4.52 (d, J = 15.0 Hz, 1H), 3.47 (dq, J = 
6.7, 5.6 Hz, 1H), 2.47 – 2.26 (m, 2H), 1.67 – 1.50 (m, 2H), 1.50 – 1.26 (m, 4H), 0.93 (t, J 
= 7.0 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 138.97, 135.12, 128.29, 127.72, 127.42, 
116.79, 78.58, 70.89, 38.33, 33.52, 27.58, 22.81, 14.11. HRMS (EI+) calc'd for C12H17O 
(M - CH2CHCH2) 177.1279, found 177.1284. 
 
 
Dec-1-en-3-yl acetate: prepared according to the literature.4  1H NMR (500 MHz, 
CDCl3) δ 5.82 – 5.72 (m, 1H), 5.26 – 5.19 (m, 2H), 5.14 (dt, J = 10.4, 1.2 Hz, 1H), 2.05 
(s, 3H), 1.72 – 1.52 (m, 2H), 1.36 – 1.23 (m, 10H), 0.90 (d, J=12.5 Hz, 3H). Spectral data 
were in accordance with the literature.4 
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2,2-Dimethyl-4-vinyl-1,3-dioxolane: prepared according to the literature.5 1H NMR 
(300 MHz, CDCl3) δ 5.82 (m, 1H), 5.36 (m, 1H), 5.22 (ddd, J = 10.3, 1.5, 0.8 Hz, 1H), 
4.50 (dtd, J = 7.3, 6.7, 6.3, 0.9 Hz, 1H), 4.11 (dd, J = 8.1, 6.2 Hz, 1H), 3.60 (t, J = 7.9 Hz, 
1H), 1.41 (d, J = 10.5 Hz, 6H). Spectral data were in accordance with the literature.5 
 
 
(((2-methylhex-5-en-3-yl)oxy)methyl)benzene: prepared according to literature. 6  1H 
NMR (500 MHz, CDCl3) δ 7.38 – 7.31 (m, 4H), 7.30 – 7.24 (m, 1H), 5.89 (ddt, J = 17.2, 
10.2, 7.1 Hz, 1H), 5.10 (ddt, J = 17.1, 2.2, 1.5 Hz, 1H), 5.05 (ddt, J = 10.2, 2.2, 1.2 Hz, 
1H), 4.58 (d, J = 10 Hz, 1H), 4.50 (d, J = 10 Hz, 1H), 3.20 (dt, J = 6.2, 5.5 Hz, 1H), 2.31 
(ddd, J = 7.3, 5.8, 1.3 Hz, 2H), 1.95 – 1.80 (m, 1H), 0.96 (d, J = 6.8 Hz, 3H), 0.93 (d, J = 
6.8 Hz, 3H). Spectral data were in accordance with the literature.6 
 
 
(1-(benzyloxy)but-3-en-1-yl)benzene: prepared according to literature.7 1H NMR (500 
MHz, CDCl3) δ 7.41 – 7.27 (m, 10H), 5.78 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H), 5.07 – 5.00 
(m, 2H), 4.47 (d, J = 12.0 Hz, 1H), 4.37 (dd, J = 7.6, 5.8 Hz, 1H), 4.27 (m, 1H), 2.65 
(dddt, J = 14.4, 7.7, 6.9, 1.3 Hz, 1H), 2.44 (dddt, J = 14.2, 7.1, 5.8, 1.3 Hz, 1H). Spectral 
data were in accordance with the literature.7 
 
 
(((4-methylhept-1-en-4-yl)oxy)methyl)benzene: NaH (60wt% dispersion in mineral oil, 
600 mg, 15 mmol) was weighed into a flask with a stir bar. Dimethylacetamide (10 mL) 
was added to the vial and the mixture was cooled to 0 ºC. 4-Methylhept-1-en-4-ol (1.28 g, 
10 mmol) was added slowly to the suspension. Benzyl bromide (1.4 mL, 12 mmol) was 
next added slowly to the reaction mixture. The reaction mixture was allowed to warm to 
room temperature and stirred overnight (ca. 10 h). The reaction mixture was diluted with 
water (ca. 125 mL) and extracted with diethyl ether (ca. 50 mL x3) and the combined 
organics were washed with brine and subsequently dried over MgSO4. Purification by 
column chromatography gave the desired compound (1.29 g, 59% yield) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.38 – 7.22 (m, 5H), 5.97 – 5.83 (m, 1H), 5.14 – 5.06 (m, 
2H), 4.44 (s, 2H), 2.43 – 2.29 (m, 2H), 1.62 – 1.49 (m, 2H), 1.48 – 1.36 (m, 2H), 1.22 (s, 
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3H), 0.94 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 139.75, 134.63, 128.22, 
127.26, 127.04, 117.18, 76.86, 63.23, 42.95, 40.42, 23.26, 16.71, 14.65. HRMS (EI+) 
calc'd for C12H17O (M - CH2CHCH2) 177.1279, found 177.1283. 
 
 
(((1-allylcyclohexyl)oxy)methyl)benzene: Prepared according to the literature.6 1H 
NMR (500 MHz, CDCl3) δ 7.40 – 7.36 (m, 2H), 7.36 – 7.31 (m, 2H), 7.28 – 7.23 (m, 
1H), 5.98 – 5.80 (m, 1H), 5.12 – 5.04 (m, 2H), 4.42 (s, 2H), 2.34 (dt, J = 7.2, 1.3 Hz, 
2H), 1.87 – 1.81 (m, 2H), 1.69 – 1.56 (m, 3H), 1.50 – 1.43 (m, 2H), 1.42 – 1.32 (m, 2H), 
1.32 – 1.20 (m, 1H). Spectral data were in accordance with the literature.6 
 
 
(trans-3-(benzyloxy)-4-methylhex-5-en-1-yl)benzene: NaH (60 wt% dispersion in 
mineral oil, 600 mg, 15 mmol) was weighed into a flask with a stir bar. 
Dimethylacetamide (10 mL) was added to the vial and the mixture was cooled to 0 ºC. 
trans-4-methyl-1-phenylhex-5-en-3-ol (1.9 g, 10 mmol) was added slowly to the 
suspension. Benzyl bromide (1.4 mL, 12 mmol) was next added slowly to the reaction 
mixture. The reaction mixture was allowed to warm to room temperature and stirred 
overnight (ca. 10 h). The reaction mixture was diluted with water (ca. 125 mL) and 
extracted with diethyl ether (ca. 50 mL x3) and the combined organics were washed with 
brine and subsequently dried over MgSO4. Purification by column chromatography gave 
the desired compound (1.47 g, 52% yield) as a colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 7.44 – 7.13 (m, 10H), 5.88 – 5.76 (m, 1H), 5.12 – 5.01 (m, 2H), 4.62 (d, J = 10.1, 1H), 
4.52 (d, J = 10.1 1H), 3.35 (dt, J = 8.4, 4.3 Hz, 1H), 2.84 – 2.76 (m, 1H), 2.60 (ddd, J = 
13.9, 9.8, 6.7 Hz, 2H), 1.88–1.70 (m, 2H), 1.05 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 142.45, 140.79, 138.87, 128.42, 128.33, 128.31, 127.81, 127.50, 125.69, 
114.64, 82.11, 71.73, 40.16, 32.46, 32.23, 14.50. HRMS (EI+) calc'd for C20H24O (M+) 
280.1827, found 280.1818. 
 
 
(R)-1-phenyl-1-(2-methylphenoxy)-2-propene: prepared according to the literature.8 1H 
NMR (500 MHz, CDCl3) δ 7.44 – 7.41 (m, 2H), 7.40 – 7.34 (m, 2H), 7.31 – 7.27 (m, 1H), 
7.16 – 7.13 (m, 1H), 7.05 (tdd, J = 8.0, 1.5, 0.9 Hz, 1H), 6.86 – 6.80 (m, 1H), 6.79 (d, J = 
8.2 Hz, 1H), 6.10 (ddd, J = 17.1, 10.4, 5.8, Hz, 1H), 5.65 (d, J = 5.8 Hz, 1H), 5.38 (d, J = 
17.3, Hz, 1H), 5.24 (dq, J = 10.4, 1.2 Hz, 1H), 2.33 (s, 3H).  Spectral data were in 
accordance with the literature.8 [α]D
 = -7.6 (c 0.94, CHCl3), which is in accordance with 
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literature values.8 HPLC analysis indicated an enantiomeric excess of 95% [Chiralcel® 
OJ-H column, eluting with 99.9:0.1 hexane/i-PrOH, 0.7 mL/min, 220 nm; (S) enantiomer 
tR, 16.2, (R) enantiomer tR 16.7 min]. 
 
4-((tert-butyldimethylsilyl)oxy)octanal (table 1, entry 1): 98.6 mg (76% yield) 
obtained using procedure A. 1H NMR (500 MHz, CDCl3) δ 9.79 (t, J = 1.7 Hz, 1H), 3.71 
(tt, J = 6.2, 4.5 Hz, 1H), 2.49 (td, J = 7.5, 1.7 Hz, 2H), 1.89 – 1.80 (m, 1H), 1.71 (dt, J = 
13.7, 6.9 Hz, 1H), 1.51 – 1.34 (m, 2H), 1.35 – 1.20 (m, 4H), 0.88, (m, 3H), 0.87 (s, 9H), 
0.04 (d, J = 4.1 Hz, 6H). Spectral data were in accordance with the literature.9 
 
 
1-oxooctan-4-yl acetate (table 1, entry 2): 70.8 mg (76% yield) obtained using 
procedure A. 1H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.4 Hz, 1H), 4.89 (dddd, J = 8.2, 
7.3, 5.4, 4.0 Hz, 1H), 2.48 (ddt, J = 8.2, 6.7, 1.3 Hz, 2H), 2.04 (s, 3H), 1.99 – 1.90 (m, 
1H), 1.88 – 1.79 (m, 1H), 1.63 – 1.46 (m, 2H), 1.36 – 1.23 (m, 4H), 0.89 (t, J = 7.0 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ 201.47, 170.82, 73.33, 39.96, 33.83, 27.40, 26.36, 
22.50, 21.15, 13.94. HRMS (EI+) calc'd for C8H15O2 (M - CH3CO) 143.1072, found 
143.1109 
 
 
4-methoxyoctanal (table 1, entry 3): 71% obtained using procedure B. 
 
 
4-phenoxybutanal (table 1, entry 4): 72.0 mg (88% yield) obtained using procedure A. 
1H NMR (500 MHz, CDCl3) δ 9.85 (t, J = 1.4 Hz, 1H), 7.32 – 7.24 (m, 2H), 6.95 (tt, J = 
7.4, 1.1 Hz, 1H), 6.88 (dt, J = 7.8, 1.0 Hz, 2H), 4.01 (t, J = 6.0 Hz, 2H), 2.68 (td, J = 7.1, 
1.3 Hz, 2H), 2.13 (tt, J = 7.0, 6.0 Hz, 2H). Spectral data were in accordance with the 
literature.10 
 
 
4-(benzyloxy)octanal (table 1, entry 5): 99.9 mg (85% yield) obtained using procedure 
A. 1H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.7 Hz, 1H), 7.40 – 7.26 (m, 5H), 4.54 – 
4.50 (m, 1H), 4.45 – 4.41 (m, 1H), 3.41 (dtd, J = 7.3, 6.0, 4.1 Hz, 1H), 2.52 (ddt, J = 7.4, 
6.9, 1.6 Hz, 2H), 1.92 (dddd, J = 14.5, 7.6, 6.9, 4.1 Hz, 1H), 1.85 – 1.76 (m, 1H), 1.62 
(dtd, J = 13.6, 5.8, 4.7 Hz, 1H), 1.52 – 1.42 (m, 1H), 1.33 (ttd, J = 6.0, 4.2, 3.2, 2.0 Hz, 
4H), 0.91 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 202.55, 138.57, 128.36, 
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127.83, 127.57, 77.91, 70.87, 40.00, 33.34, 27.42, 26.28, 22.84, 14.06. HRMS (EI+) 
calc'd for C15H22O2 (M+) 234.1620, found 234.1632. 
 
 
1-oxodecan-3-yl acetate (table 1, entry 6): 75% obtained using procedure B.  
 
 
3-phenoxypropanal (table 1, entry 7): 61.3 mg (82% yield) obtained using procedure 
A. 1H NMR (500 MHz, CDCl3) δ 9.76 (t, J = 1.7 Hz, 1H), 7.32 – 7.27 (m, 2H), 7.00 – 
6.95 (m, 1H), 6.93 – 6.90 (m, 2H), 4.32 (t, J = 6.1 Hz, 2H), 2.91 (td, J = 6.1, 1.6 Hz, 2H). 
Spectral data were in accordance with the literature.11 
 
 
2-(2,2-dimethyl-1,3-dioxolan-4-yl)acetaldehyde (table 1, entry 8): 64% yield obtained 
using procedure B. 
 
 
4-(benzyloxy)-5-methylhexanal (table 2, entry 1): 88.1 mg (80% yield) obtained using 
procedure A. 1H NMR (500 MHz, CDCl3) δ 9.66 (t, J = 1.7 Hz, 1H), 7.30 – 7.17 (m, 
5H), 4.46 (d, J = 12.5, 1H), 4.34 (d, J = 12.5 1H), 3.11 (ddd, J = 8.6, 5.4, 3.4 Hz, 1H), 
2.43 (m, 2H), 1.90 (dtd, J = 13.7, 6.9, 5.4 Hz, 1H), 1.78 (m, 1H), 1.70 (m, 1H), 0.89 (d, J 
= 6.9 Hz, 3H), 0.85 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 202.68, 138.60, 
128.35, 127.85, 127.57, 83.14, 71.64, 40.39, 30.27, 22.49, 18.72, 17.30. HRMS (EI+) 
calc'd for C14H20O2 (M+) 220.1463, found 220.1466. 
 
 
4-(benzyloxy)-4-phenylbutanal (table 2, entry 2): 94.1 mg (74% yield) obtained using 
procedure A. 1H NMR (500 MHz, CDCl3) δ 9.74 (t, J = 1.6 Hz, 1H), 7.35 (m, 10H), 4.47 
(d, J = 11.7 Hz, 1H), 4.37 (dd, J = 8.3, 4.8 Hz, 1H), 4.25 (d, J = 11.7 Hz, 1H), 2.54 (m, 
2H), 2.14 (ddt, J = 14.2, 8.4, 7.1 Hz, 1H), 2.04 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 
202.21, 141.55, 138.18, 128.60, 128.38, 127.87, 127.81, 127.62, 126.63, 80.20, 70.52, 
40.46, 30.91. HRMS (EI+) calc'd for C11H13O2 (M - C6H5) 177.0916, found 177.0956. 
 
 
4-(benzyloxy)-4-methylheptanal (table 2, entry 3): 90.2 mg (77% yield) obtained using 
procedure A except NaNO2 is replaced with AgNO2 and the reaction is allowed to 
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proceed for 24 h. Isolated as an inseparable mixture of aldehyde and ketone (9:1). 
Spectral data reported for aldehyde product (major). 1H NMR (500 MHz, CDCl3) δ 9.79 
(t, J = 1.6 Hz, 1H), 7.35 – 7.31 (m, 4H), 7.28 – 7.24 (m, 1H), 4.37 (s, 2H), 2.55 (ddt, J = 
8.4, 6.7, 1.6 Hz, 2H), 1.99 – 1.92 (m, 1H), 1.89 – 1.80 (m, 1H), 1.60 – 1.50 (m, 2H), 1.43 
– 1.35 (m, 2H), 1.23 (s, 3H), 0.95 (t, J = 7.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 
202.66, 139.36, 128.30, 127.23, 127.19, 76.23, 63.25, 40.66, 38.73, 30.32, 23.02, 17.04, 
14.69. HRMS (EI+) calc'd for C13H19O (M - CH2CHO) 191.1436, found 191.1444. 
 
 
3-(1-(benzyloxy)cyclohexyl)propanal: 94.8 mg (77% yield) obtained using procedure A 
except NaNO2 is replaced with AgNO2 and the reaction is allowed to proceed for 24 h. 
1H NMR (500 MHz, CDCl3) δ 9.81 (t, J = 1.4 Hz, 1H), 7.38 – 7.32 (m, 4H), 7.29 – 7.24 
(m, 1H), 4.35 – 4.29 (s, 2H), 2.54 (ddd, J = 9.1, 6.5, 1.5 Hz, 2H), 1.87 (m, 4H), 1.63 (m, 
3H), 1.48 (m, 2H), 1.32 (m, 3H). 13C NMR (101 MHz, CDCl3) δ 202.58, 139.30, 128.31, 
127.23, 127.18, 74.77, 62.24, 37.90, 34.45, 28.51, 25.85, 21.92. HRMS (EI+) calc'd for 
C16H22O2 (M+) 246.1620, found 246.1618. 
 
 
trans-4-(benzyloxy)-3-methyl-6-phenylhexanal: 96.3 mg (65% yield) obtained using 
procedure A except NaNO2 is replaced with AgNO2 and the reaction is allowed to 
proceed for 24 h. 1H NMR (500 MHz, CDCl3) δ 9.72 (t, J = 2.1 Hz, 1H), 7.38 – 7.14 (m, 
10H), 4.55 – 4.48 (m, 2H), 3.26 (td, J = 6.1, 4.3 Hz, 1H), 2.77 (ddd, J = 13.7, 9.9, 6.0 Hz, 
1H), 2.66 (ddd, J = 13.8, 10.0, 6.7 Hz, 1H), 2.50 – 2.43 (m, 2H), 2.34 – 2.26 (m, 1H), 
1.90 – 1.81 (m, 2H), 1.00 (d, J = 6.7 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 202.07, 
142.18, 138.39, 128.43, 128.39, 128.34, 127.92, 127.66, 125.86, 82.08, 71.66, 47.86, 
32.27, 31.27, 31.06, 16.36. HRMS (EI+) calc'd for C20H24O2 (M+) 296.1776, found 
296.1778. 
 
 
 
 
 
 
(R)-3-phenyl-3-(2-methylphenoxy)propanal: 85.3 mg (71% yield) obtained using 
procedure A except NaNO2 is replaced with AgNO2. 1H NMR (500 MHz, CDCl3) δ 9.88 
(dd, J = 2.5, 1.6 Hz, 1H), 7.41 – 7.33 (m, 4H), 7.32 – 7.27 (m, 1H), 7.13 (ddd, J = 7.4, 
1.7, 0.9 Hz, 1H), 6.98 (td, J = 8.1, 1.7 Hz, 1H), 6.82 (td, J = 7.4, 1.1 Hz, 1H), 6.65 (dd, J 
= 8.1, 1.2 Hz, 1H), 5.72 (dd, J = 8.6, 4.2 Hz, 1H), 3.15 (ddd, J = 16.6, 8.6, 2.6 Hz, 1H), 
2.88 (ddd, J = 16.6, 4.2, 1.6 Hz, 1H), 2.28 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
199.83, 155.38, 140.36, 130.77, 128.91, 128.06, 127.16, 126.58, 125.67, 120.88, 112.88, 
74.88, 51.91, 16.42. HRMS (EI+) calc'd for C16H16O2 (M+) 240.1150, found 240.1155. 
OBn
O
OBn
Ph
Me
O
Ph
O
Me
O
 S9 
[α]D = -10.1 (c 0.48, CHCl3). Enantiomeric excess checked by derivatization to 
atomoxetine (vide infra). 
 
 
(R)-3-phenyl-3-(2-methylphenoxy)propanal was derivatized to atomoxetine by treatment 
of the aldehyde with excess NaBH3CN (ca. 3 equiv) and methylamine hydrochloride (ca. 
50 equiv) to provided a crude mixture (37% yield of atomoxetine according to 1H NMR 
analysis), which was purified by preparatory thin layer chromatography for 
characterization and determination of enantiomeric excess. 1H NMR (500 MHz, CDCl3) 
δ 7.37 – 7.29 (m, 4H), 7.27 – 7.22 (m, 1H), 7.12 (ddd, J = 7.3, 1.7, 0.9 Hz, 1H), 6.98 – 
6.92 (m, 1H), 6.78 (td, J = 7.4, 1.1 Hz, 1H), 6.62 – 6.58 (m, 1H), 5.28 (dd, J = 8.3, 4.4 
Hz, 1H), 2.90 – 2.80 (m, 2H), 2.47 (s, 3H), 2.32 (s, 3H), 2.30 – 2.19 (m, 1H), 2.11 (dtd, J 
= 14.2, 7.3, 4.5 Hz, 1H). Spectral data were in accordance with the literature.12 [α]D
 = -
31.6 (c 0.10, CHCl3), which is in accordance with literature values.12 SFC analysis 
indicated an enantiomeric excess of 94% [Chiralcel® OD-H column, eluting with 20% 
MeOH, 2.5 mL/min, 220 nm; (S) enantiomer tR, 3.95, (R) enantiomer tR 5.4 min]. 
 
Intramolecular competition experiments 
 
Each initial rate measurement was made in duplicate and the values averaged. The 
following procedure was used: PdCl2(PhCN)2 (0.02 mmol, 7.7 mg), CuCl2•2H2O (0.02 
mmol, 3.6 mg) and NaNO2 (0.01 mmol, 0.7 mg) were weighed into a 8 mL vial charged 
with a stir bar. The vial was sparged for 1 minute with oxygen (1 atm, balloon). Premixed 
and oxygen saturated t-BuOH (3 mL) and MeNO2 (0.2 mL) was added followed by the 
addition of pre-mixed alkenes (0.1 mmol of each alkene). The solution was saturated with 
oxygen by an additional 10 seconds of sparging. The reaction was then allowed to stir at 
room temperature (20-25ºC) for 10 minutes. Next, the reaction was quenched by addition 
of pyridine (5 µL) and then water (10mL) and extracted three times with dichloromethane 
(ca. 5 mL). The combined organic layers were subsequently washed with a saturated 
solution of NaHCO3 (ca. 5 mL) and dried over Na2SO4. The resulting solution was 
subjected to 1H NMR analysis to determine relative rates. Benzonitrile signals were used 
as an internal standard to confirm that conversion  was <15% in each case. 
 
The selectivity of each substrate under the nitrite-modified Wacker was independently 
measured using procedure B. 
                                                
12 Tetrahedron: Asymmetry 2013, 24, 913 - 918 
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